Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a phase I trial

著者: Byeong-Ho Park, Tae-Ho Hwang, Ta‐Chiang Liu, Daniel Y. Sze, Jae‐Seok Kim, Hyuk‐Chan Kwon, Sung Yong Oh, Sang‐Young Han, Jin-Han Yoon, Sook Hee Hong, Anne Moon, Kelly Speth, Chohee Park, Young‐joo Ahn, Manijeh Daneshmand, Byung Geon Rhee, Herbert M. Pinedo, John C. Bell, David H. Kirn - The Lancet 2008 被引用: 522